Nevirapine (known as Viramune prolonged-release)

Generic name: Nevirapine

Brand names: Viramune prolonged-release

Class: NNRTIs (Non-nucleoside reverse transcriptase inhibitors)

Side-effects:

Common: Liver toxicity, allergic reaction, rash, nausea, headache, fatigue, stomach pain, diarrhoea
Rare: Severe rash (Stevens Johnson syndrome)

Dosage:

400mg tablet
400mg once a day after introductory period on non-prolonged release nevirapine

Notes:

Take with or without food.

This article was last reviewed on 19/12/2011 by T. Kelaart.

Date due for the next review: 30/9/2014.

If you have any questions or comments about this resource, or would like information on the evidence used to produce it, please email feedback@tht.org.uk. The information included on this website was correct at the time of publication.

Data and image supplied by NAM.